Winner Medical(SZ:300888) Sou Hu Cai Jing·2026-01-15 12:36Core Viewpoint - The stock of Steady Medical (300888) has experienced a decline, with a closing price of 38.08 yuan on January 15, 2026, down 3.57% from the previous day, indicating a potential shift in investor sentiment and market dynamics [1]. Financial Performance - For the first three quarters of 2025, Steady Medical reported a main revenue of 7.897 billion yuan, a year-on-year increase of 30.1% [3]. - The net profit attributable to shareholders was 732 million yuan, up 32.36% year-on-year, while the net profit excluding non-recurring items reached 679 million yuan, reflecting a 43.93% increase [3]. - In Q3 2025 alone, the company achieved a main revenue of 2.601 billion yuan, a 27.71% increase year-on-year, and a net profit of 240 million yuan, up 42.11% year-on-year [3]. Market Position - Steady Medical's total market capitalization stands at 22.175 billion yuan, ranking 4th in the beauty and personal care industry, which has an average market cap of 10.475 billion yuan [3]. - The company has a net asset value of 12.263 billion yuan, significantly higher than the industry average of 3.361 billion yuan, ranking 1st in the industry [3]. - The company's price-to-earnings ratio (P/E) is 22.72, which is lower than the industry average of 39.18, ranking 2nd in the industry [3]. Investment Sentiment - Over the past 90 days, 22 institutions have rated the stock, with 18 buy ratings and 4 hold ratings, indicating strong institutional interest [4]. - The average target price set by institutions for the stock is 54.88 yuan, suggesting potential upside from the current trading price [4]. Capital Flow Analysis - On January 15, 2026, the net inflow of main funds was 21.9313 million yuan, accounting for 5.01% of the total transaction amount, while retail investors saw a net outflow of 45.2048 million yuan, representing 10.34% of the total [1][2].